Literature DB >> 24006083

Racial disparities in hepatitis B infection in Ohio: screening and immunization are critical for early clinical management.

Ranjita Misra1, Karen Jiobu, Johnathan Zhang, Qihui Liu, Feng Li, Robert Kirkpatrick, Jason Ho.   

Abstract

OBJECTIVE: Chronic hepatitis B virus (HBV) infection and liver cancer mortality represent a neglected health disparity among Asian Americans. The purposes of this study were to compare the prevalence of hepatitis B among a diverse group of 1311 Ohioans in Franklin County, OH (85% Asians, 7.5% African Americans, and 6.5% whites) and to improve access to care for high-risk Asian adults through advocacy and policy changes. RESEARCH DESIGN AND METHODS: The Asian subgroups comprised of Chinese, Filipino, Asian Indian, Pakistani, Vietnamese, Korean, Laotian, Indonesian, Japanese, Cambodian, Thai, and Malaysian nationalities. The HBV screening was completed at health fairs, restaurants, churches, and temples from 2006 to 2011.
RESULTS: The prevalence of HBV infection (9.5% vs 5%) and family history of liver cancer was significantly higher among Asians than other racial ethnic groups (P = 0.001). Cambodian, Vietnamese, and Chinese participants were disproportionately infected with the virus compared with other Asian subgroups (P < 0.001). Advocacy and policy changes for resources allowed vaccine-eligible Asians included as "high risk" group to receive free vaccinations at the health department. However, although vouchers were provided to vaccine-eligible Asian adults, compliance in getting vaccinated was very low (11%). Common barriers for compliance were lack of time and knowledge of completing the 3 shot series, low English proficiency, and fear of adverse effects.
CONCLUSIONS: Outreach education may use community liaisons to improve screenings, education, and vaccination/treatment. A hepatitis free clinic was established in 2009 to provide culturally and linguistically appropriate treatment for low-income Asian Americans in Franklin County, OH.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24006083     DOI: 10.2310/JIM.0b013e3182a70f10

Source DB:  PubMed          Journal:  J Investig Med        ISSN: 1081-5589            Impact factor:   2.895


  6 in total

1.  Chronic hepatitis B and liver cancer risks among Asian immigrants in New York City: Results from a large, community-based screening, evaluation, and treatment program.

Authors:  Henry J Pollack; Simona C Kwon; Su H Wang; Laura C Wyatt; Chau Trinh-Shevrin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-11       Impact factor: 4.254

2.  Cluster-Randomized Trial to Increase Hepatitis B Testing among Koreans in Los Angeles.

Authors:  Roshan Bastani; Beth A Glenn; Annette E Maxwell; Angela M Jo; Alison K Herrmann; Catherine M Crespi; Weng K Wong; L Cindy Chang; Susan L Stewart; Tung T Nguyen; Moon S Chen; Victoria M Taylor
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-06-23       Impact factor: 4.254

3.  Hepatitis B Vaccination Rate in Patients with Diabetes: Assessment of Racial and Socioeconomic Disparity.

Authors:  Ayse Aytaman; Nwakile Ojike; Samantha Zizi; S R Pandi-Perumal; Ismet Lukolic; Amit Bhanvadia; Felix Nwamaghinna; Haroon Kamran; Alla Akivis; Olusegun Bankole; Moro O Salifu; Samy I McFarlane
Journal:  Int J Clin Endocrinol Metab       Date:  2016-12-30

Review 4.  Advancing Health Disparities Research: The Need to Include Asian American Subgroup Populations.

Authors:  Stephanie Yom; Maichou Lor
Journal:  J Racial Ethn Health Disparities       Date:  2021-11-17

5.  Lay Health Worker Intervention Improved Compliance with Hepatitis B Vaccination in Asian Americans: Randomized Controlled Trial.

Authors:  Hee-Soon Juon; Carol Strong; Frederic Kim; Eunmi Park; Sunmin Lee
Journal:  PLoS One       Date:  2016-09-12       Impact factor: 3.240

6.  Online versus in-person training of community health workers to enhance hepatitis B virus screening among Korean Americans: Evaluating cost & outcomes.

Authors:  Theresa I Shireman; Alexander C Adia; Yin Tan; Lin Zhu; Joanne Rhee; Olorunseun O Ogunwobi; Grace X Ma
Journal:  Prev Med Rep       Date:  2020-05-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.